Time to deterioration in quality of life score as a modality of longitudinal analysis in patients with breast cancer.
about
Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patientsImpact of response shift on time to deterioration in quality of life scores in breast cancer patients.A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study.Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study.STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer.Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III TrialAn explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma.Evaluation of efficacy and efficiency of a pragmatic intervention by a social worker to support informal caregivers of elderly patients (The ICE Study): study protocol for a randomized controlled trialApplying the Longitudinal Model from Item Response Theory to Assess Health-Related Quality of Life in the PRODIGE 4/ACCORD 11 Randomized Trial.Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomised controlled trial, the PEPs fatigue study.Beware! Reduced Functional Capacity and Quality of Life with Increased Fatigue Level among the Breast Cancer Survivors Undergoing Chemotherapy in India.
P2860
Q33590470-99A1F4D7-997B-4854-882F-A8FC1E1BB586Q33610112-6E4ABFF5-65F7-415C-921B-E0889A3C76A8Q33823991-7F5CF17C-0620-4A12-8C29-BE2C3532473EQ34807981-C75EB7B9-E13C-48B0-932D-5EE12FC2BD11Q35079333-E635A03B-E42A-4690-AAF0-0B3E0BDBD143Q35682543-99E1CC33-075D-4E40-9702-807D39A363BEQ36054226-A448064A-F628-46B9-8AE4-858CA87036ECQ37063738-87942ECA-BE42-4BBC-91FB-4323340C14E2Q37436377-9846CF52-9A0A-4ACD-99BE-DADE38980853Q40195435-C2F4D9AC-EA3F-476D-85EA-B61510574B93Q40336720-AD5AA1A4-A4CB-4D0B-81FA-58BE08B73A14Q49386422-08E7D1B1-8795-4E10-BFFE-1D261328FA2E
P2860
Time to deterioration in quality of life score as a modality of longitudinal analysis in patients with breast cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Time to deterioration in quali ...... n patients with breast cancer.
@ast
Time to deterioration in quali ...... n patients with breast cancer.
@en
type
label
Time to deterioration in quali ...... n patients with breast cancer.
@ast
Time to deterioration in quali ...... n patients with breast cancer.
@en
prefLabel
Time to deterioration in quali ...... n patients with breast cancer.
@ast
Time to deterioration in quali ...... n patients with breast cancer.
@en
P2093
P2860
P1433
P1476
Time to deterioration in quali ...... n patients with breast cancer.
@en
P2093
Catherine Loustalot
Christian Rosburger
Franck Bonnetain
Hervé Tixier
Jean Cuisenier
Jean Fraisse
Jean-Marc Sauzedde
Jean-Philibert Combier
Marc Smail
Marie-Martine Padeano
P2860
P304
P356
10.1634/THEONCOLOGIST.2011-0085
P577
2011-09-23T00:00:00Z